These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2556196)

  • 1. Cytomegalovirus in blood from blood donors.
    Contreras M; Barbara JA; McDonald C
    BMJ; 1989 Oct; 299(6707):1098. PubMed ID: 2556196
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistence of cytomegalovirus in peripheral blood from blood donors.
    Morris DJ; Kimptoh CP; Corbitt G
    BMJ; 1989 Nov; 299(6708):1164-5. PubMed ID: 2557105
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors.
    Stanier P; Taylor DL; Kitchen AD; Wales N; Tryhorn Y; Tyms AS
    BMJ; 1989 Oct; 299(6704):897-8. PubMed ID: 2555001
    [No Abstract]   [Full Text] [Related]  

  • 4. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India.
    Kothari A; Ramachandran VG; Gupta P; Singh B; Talwar V
    J Health Popul Nutr; 2002 Dec; 20(4):348-51. PubMed ID: 12659416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytomegalovirus infection in blood donors].
    Pana A; Santi AL; Purpura M; Conforti GB; Castello C; Divizia M
    Nuovi Ann Ig Microbiol; 1976; 27(6):501-10. PubMed ID: 212717
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid detection of cytomegalovirus with monoclonal antibody in blood component donors: a simple screening for hemotherapy in a bone marrow transplantation program.
    D'Antonio D; Angelini A; Iacone A; Dragani A; Di Gianfilippo R; Accorsi P; Quaglietta A; Geraci L; Berardi A; Dell'Isola M
    Haematologica; 1988; 73(6):495-7. PubMed ID: 2853121
    [No Abstract]   [Full Text] [Related]  

  • 7. [Detection of human cytomegalovirus infection in blood donor population by the polymerase chain reaction].
    Wang G; Lai F; He M; Jing Z; Yu Y
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):206-8. PubMed ID: 9868113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.
    Ziemann M; Krueger S; Maier AB; Unmack A; Goerg S; Hennig H
    Transfusion; 2007 Nov; 47(11):1972-83. PubMed ID: 17958525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent cytomegalovirus infection in blood donors.
    Diosi P; Moldovan E; Tomescu N
    Br Med J; 1969 Dec; 4(5684):660-2. PubMed ID: 4311727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of donor cytomegalovirus DNA on transfusion strategies for at-risk patients.
    Ziemann M; Juhl D; Görg S; Hennig H
    Transfusion; 2013 Oct; 53(10):2183-9. PubMed ID: 23581526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The post-transfusion syndrome and Cytomegalovirus.
    Lancet; 1969 Sep; 2(7619):526-7. PubMed ID: 4184843
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of cytomegalovirus in Thai blood donors by monoclonal staining of blood leukocytes.
    Amarapal P; Tantivanich S; Balachandra K
    Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):148-53. PubMed ID: 11485078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnostic of cytomegalovirus, Epstein Barr virus and Herpes virus 6 infections among blood donors by multiplex real-time PCR in Ouagadougou, Burkina Faso.
    Traore L; Tao I; Bisseye C; Diarra B; Compaore TR; Nebie Y; Assih M; Ouedraogo A; Zohoncon T; Djigma F; Ouermi D; Barro N; Sanou M; Ouedraogo RT; Simpore J
    Pan Afr Med J; 2016; 24():298. PubMed ID: 28154653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Window period donations during primary cytomegalovirus infection and risk of transfusion-transmitted infections.
    Ziemann M; Heuft HG; Frank K; Kraas S; Görg S; Hennig H
    Transfusion; 2013 May; 53(5):1088-94. PubMed ID: 23320406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular biological screening of viruses important to transfusion medicine].
    Wolff C; Hörnschemeyer D; Skurtopulos M; Petersen N; Beyer J; Seidel K; Mutz A; Kleesiek K
    Beitr Infusionsther Transfusionsmed; 1994; 32():102-9. PubMed ID: 9480064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of demographic variables on cytomegalovirus antibody seropositivity among prospective blood donors in Jos, Nigeria.
    Alao OO; Mamman A; Araoye MO; Joseph E
    Niger Postgrad Med J; 2009 Jun; 16(2):139-42. PubMed ID: 19606194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Human cytomegalovirus (HCMV). Position of the Blood Working Group of the Federal Ministry of Health].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):973-83. PubMed ID: 20853094
    [No Abstract]   [Full Text] [Related]  

  • 18. Infectivity of blood products containing cytomegalovirus DNA: results of a lookback study in nonimmunocompromised patients.
    Ziemann M; Juhl D; Brockmann C; Görg S; Hennig H
    Transfusion; 2017 Jul; 57(7):1691-1698. PubMed ID: 28370032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of the role of cytomegalovirus in post-transfusion mononucleosis.
    Foster KM; Jack I
    N Engl J Med; 1969 Jun; 280(24):1311-6. PubMed ID: 4306161
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the frequency of intrauterine infections with cytmegalic virus].
    Krech U; Jung M; Bärlocher K; Sege L
    Dtsch Med Wochenschr; 1968 Mar; 93(11):469-74. PubMed ID: 4295483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.